Health New England announced Monday that it will shift coverage of the biologic drug Humira to more affordable FDA-approved ...

Switching to Humira biosimilars saved Navitus clients more than $315 million in upfront costs in 2024 and resulted in a 60% ...

Adalimumab (Humira), adalimumab-adaz(Hyrimoz), adalimumab ... The drugs below can treat rheumatoid arthritis, although only a few are available on the market: Biosimilars of infliximab (Remicade ...

Samsung Bioepis and Organon shared that the Food and Drug Administration has designated the Hadlima (adalimumab-bwwd) high- ...

The FDA has expanded the interchangeable designation for Yuflyma (adalimumab-aaty), a biosimilar to Humira, to include all presentations.

AbbVie claimed FDA approval for its JAK inhibitor Rinvoq (upadacitinib) for rheumatoid arthritis on Friday, setting its price just a little below that of its antibody blockbuster Humira.

Drugmaker Boehringer Ingelheim and prescription savings platform GoodRx have teamed up to provide Boehringer’s Humira biosimilar ... including rheumatoid arthritis, Crohn’s disease, psoriatic ...

As the healthcare industry and consumers contend with rising prescription drug spending, AbbVie's popular rheumatoid arthritis biologic Humira, which brandishes a $7,000 monthly list price ...

In 2006 AbbVie launched the Humira Pen, a self-injecting device, and it is currently in Phase III clinical trials for three additional indications – unspecified arthritis, peripheral ...

DEAR DR. ROACH: I’m a 67-year-old healthy male, but I do take Humira for rheumatoid arthritis (RA). It does a wonderful job for me with no side effects. It does such a good job that I can ...

Psoriatic arthritis (PsA) has been around for thousands of years. Archaeologists unearthed Egyptian mummies with signs of the disease. Back then, the treatments for swollen and painful joints and ...